CDGIIB
MCID: CNG190
MIFTS: 42

Congenital Disorder of Glycosylation, Type Iib (CDGIIB)

Categories: Blood diseases, Bone diseases, Cardiovascular diseases, Ear diseases, Endocrine diseases, Eye diseases, Fetal diseases, Gastrointestinal diseases, Genetic diseases, Immune diseases, Liver diseases, Mental diseases, Metabolic diseases, Muscle diseases, Nephrological diseases, Neuronal diseases, Rare diseases, Skin diseases

Aliases & Classifications for Congenital Disorder of Glycosylation, Type Iib

MalaCards integrated aliases for Congenital Disorder of Glycosylation, Type Iib:

Name: Congenital Disorder of Glycosylation, Type Iib 58 13 74
Congenital Disorder of Glycosylation Type Iib 12 60 15
Congenital Disorder of Glycosylation Type 2b 60 30 6
Cdgiib 58 12 76
Cdg2b 58 12 60
Glucosidase I Deficiency 58 76
Cdg Iib 58 12
Carbohydrate Deficient Glycoprotein Syndrome Type Iib 60
Glycosylation, Congenital Disorder of, Type Iib 41
Type Iib Congenital Disorder of Glycosylation 76
Glucosidase I Deficiency\n 12
Glucosidase 1 Deficiency 60
Cdg Syndrome Type Iib 60
Cdg Iib; Cdgiib 58
Glucosidase I 13
Mogs-Cdg 60
Cdg-Iib 60

Characteristics:

Orphanet epidemiological data:

60
mogs-cdg
Inheritance: Autosomal recessive; Prevalence: <1/1000000 (Worldwide); Age of onset: Infancy,Neonatal; Age of death: early childhood;

OMIM:

58
Inheritance:
autosomal recessive

Miscellaneous:
onset at birth
two families have been reported (last curated april 2014)


HPO:

33
congenital disorder of glycosylation, type iib:
Onset and clinical course congenital onset
Inheritance autosomal recessive inheritance


Classifications:



Summaries for Congenital Disorder of Glycosylation, Type Iib

UniProtKB/Swiss-Prot : 76 Type IIb congenital disorder of glycosylation: Characterized by marked generalized hypotonia and hypomotility of the neonate, dysmorphic features, including a prominent occiput, short palpebral fissures, retrognathia, high arched palate, generalized edema, and hypoplastic genitalia. Symptoms of the infant included hepatomegaly, hypoventilation, feeding problems and seizures. The clinical course was progressive and the infant did not survive more than a few months.

MalaCards based summary : Congenital Disorder of Glycosylation, Type Iib, also known as congenital disorder of glycosylation type iib, is related to congenital disorder of glycosylation, type in and congenital disorder of glycosylation, type ii, and has symptoms including seizures An important gene associated with Congenital Disorder of Glycosylation, Type Iib is MOGS (Mannosyl-Oligosaccharide Glucosidase), and among its related pathways/superpathways are Transport to the Golgi and subsequent modification and Galactose metabolism. Affiliated tissues include liver, and related phenotypes are seizures and failure to thrive

Disease Ontology : 12 A congenital disorder of glycosylation type II that has material basis in an autosomal recessive mutation of MOGS on chromosome 2p13.1.

Description from OMIM: 606056

Related Diseases for Congenital Disorder of Glycosylation, Type Iib

Diseases in the Congenital Disorder of Glycosylation, Type Ii family:

Congenital Disorder of Glycosylation, Type Ia Congenital Disorder of Glycosylation, Type Iia
Congenital Disorder of Glycosylation, Type I/iix Congenital Disorder of Glycosylation, Type Iic
Congenital Disorder of Glycosylation, Type Iim Congenital Disorder of Glycosylation, Type Iy
Congenital Disorder of Glycosylation, Type Id Congenital Disorder of Glycosylation, Type Ib
Congenital Disorder of Glycosylation, Type Ic Congenital Disorder of Glycosylation, Type Iif
Congenital Disorder of Glycosylation, Type Iib Congenital Disorder of Glycosylation, Type Iid
Congenital Disorder of Glycosylation, Type Ig Congenital Disorder of Glycosylation, Type Ij
Congenital Disorder of Glycosylation, Type Ih Congenital Disorder of Glycosylation, Type Ik
Congenital Disorder of Glycosylation, Type Il Congenital Disorder of Glycosylation, Type Ie
Congenital Disorder of Glycosylation, Type if Congenital Disorder of Glycosylation, Type Im
Congenital Disorder of Glycosylation, Type Iih Congenital Disorder of Glycosylation, Type Iig
Congenital Disorder of Glycosylation, Type in Congenital Disorder of Glycosylation, Type Iq
Congenital Disorder of Glycosylation, Type Iij Congenital Disorder of Glycosylation, Type Iii
Congenital Disorder of Glycosylation, Type Ip Congenital Disorder of Glycosylation, Type Ir
Congenital Disorder of Glycosylation, Type Iil Congenital Disorder of Glycosylation, Type Iik
Congenital Disorder of Glycosylation, Type It Congenital Disorder of Glycosylation, Type Iu
Congenital Disorder of Glycosylation, Type Iw Congenital Disorder of Glycosylation, Type Ix
Congenital Disorder of Glycosylation, Type Iin Congenital Disorder of Glycosylation, Type Iio
Congenital Disorder of Glycosylation, Type Iip Congenital Disorder of Glycosylation, Type Iiq

Diseases related to Congenital Disorder of Glycosylation, Type Iib via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 congenital disorder of glycosylation, type in 30.0 MAN1B1 MOGS
2 congenital disorder of glycosylation, type ii 10.1 MAN1B1 MOGS
3 maxillary sinus squamous cell carcinoma 9.7 CALR CANX
4 myeloperoxidase deficiency 9.7 CALR CANX
5 immune system disease 9.5 CALR CANX

Graphical network of the top 20 diseases related to Congenital Disorder of Glycosylation, Type Iib:



Diseases related to Congenital Disorder of Glycosylation, Type Iib

Symptoms & Phenotypes for Congenital Disorder of Glycosylation, Type Iib

Human phenotypes related to Congenital Disorder of Glycosylation, Type Iib:

60 33 (show all 26)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 seizures 60 33 hallmark (90%) Very frequent (99-80%) HP:0001250
2 failure to thrive 60 33 hallmark (90%) Very frequent (99-80%) HP:0001508
3 hepatic failure 60 33 hallmark (90%) Very frequent (99-80%) HP:0001399
4 high palate 33 HP:0000218
5 muscular hypotonia 33 HP:0001252
6 global developmental delay 33 HP:0001263
7 hepatomegaly 33 HP:0002240
8 sensorineural hearing impairment 33 HP:0000407
9 optic atrophy 33 HP:0000648
10 feeding difficulties in infancy 33 HP:0008872
11 abnormality of metabolism/homeostasis 33 HP:0001939
12 retrognathia 33 HP:0000278
13 prominent occiput 33 HP:0000269
14 decreased antibody level in blood 33 HP:0004313
15 recurrent fractures 33 HP:0002757
16 blepharophimosis 33 HP:0000581
17 long eyelashes 33 HP:0000527
18 wide nose 33 HP:0000445
19 hypoventilation 33 HP:0002791
20 generalized hypotonia 33 HP:0001290
21 hypoplasia of the corpus callosum 33 HP:0002079
22 overlapping fingers 33 HP:0010557
23 cerebral atrophy 33 HP:0002059
24 hand clenching 33 HP:0001188
25 short palpebral fissure 33 HP:0012745
26 thoracic scoliosis 33 HP:0002943

Symptoms via clinical synopsis from OMIM:

58
Neurologic Central Nervous System:
seizures
cerebral atrophy
hypotonia
delayed psychomotor development
small corpus callosum

Head And Neck Face:
retrognathia

Skeletal:
recurrent fractures

Skin Nails Hair Hair:
long eyelashes

Skeletal Hands:
overlapping fingers
clenched hands

Head And Neck Mouth:
high-arched palate

Head And Neck Ears:
hearing loss, sensorineural

Laboratory Abnormalities:
hypogammaglobulinemia
glucosidase i deficiency in liver and fibroblasts
abnormal urinary oligosaccharides

Abdomen Liver:
hepatomegaly

Head And Neck Head:
prominent occiput

Head And Neck Eyes:
long eyelashes
short palpebral fissures
optic nerve atrophy

Respiratory:
hypoventilation

Skeletal Spine:
thoracic scoliosis

Head And Neck Nose:
broad nose

Abdomen Gastrointestinal:
feeding problems

Clinical features from OMIM:

606056

UMLS symptoms related to Congenital Disorder of Glycosylation, Type Iib:


seizures

GenomeRNAi Phenotypes related to Congenital Disorder of Glycosylation, Type Iib according to GeneCards Suite gene sharing:

27
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased gamma-H2AX phosphorylation GR00053-A 9.02 CALR CANX CHL1 MAN1B1 MGAM

Drugs & Therapeutics for Congenital Disorder of Glycosylation, Type Iib

Search Clinical Trials , NIH Clinical Center for Congenital Disorder of Glycosylation, Type Iib

Genetic Tests for Congenital Disorder of Glycosylation, Type Iib

Genetic tests related to Congenital Disorder of Glycosylation, Type Iib:

# Genetic test Affiliating Genes
1 Congenital Disorder of Glycosylation Type 2b 30 MOGS

Anatomical Context for Congenital Disorder of Glycosylation, Type Iib

MalaCards organs/tissues related to Congenital Disorder of Glycosylation, Type Iib:

42
Liver

Publications for Congenital Disorder of Glycosylation, Type Iib

Articles related to Congenital Disorder of Glycosylation, Type Iib:

# Title Authors Year
1
Processing of N-linked carbohydrate chains in a patient with glucosidase I deficiency (CDG type IIb). ( 12145188 )
2002
2
A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. ( 10788335 )
2000

Variations for Congenital Disorder of Glycosylation, Type Iib

UniProtKB/Swiss-Prot genetic disease variations for Congenital Disorder of Glycosylation, Type Iib:

76
# Symbol AA change Variation ID SNP ID
1 MOGS p.Arg486Thr VAR_018966 rs121909291
2 MOGS p.Phe652Leu VAR_018967 rs121909292

ClinVar genetic disease variations for Congenital Disorder of Glycosylation, Type Iib:

6 (show top 50) (show all 92)
# Gene Variation Type Significance SNP ID Assembly Location
1 MOGS NM_006302.2(MOGS): c.329G> A (p.Arg110His) single nucleotide variant Likely pathogenic rs863225089 GRCh37 Chromosome 2, 74692046: 74692046
2 MOGS NM_006302.2(MOGS): c.329G> A (p.Arg110His) single nucleotide variant Likely pathogenic rs863225089 GRCh38 Chromosome 2, 74464919: 74464919
3 MOGS NM_006302.2(MOGS): c.2017G> A (p.Val673Ile) single nucleotide variant Benign rs114933392 GRCh37 Chromosome 2, 74688899: 74688899
4 MOGS NM_006302.2(MOGS): c.2017G> A (p.Val673Ile) single nucleotide variant Benign rs114933392 GRCh38 Chromosome 2, 74461772: 74461772
5 MOGS NM_006302.2(MOGS): c.1457G> C (p.Arg486Thr) single nucleotide variant Pathogenic rs121909291 GRCh37 Chromosome 2, 74689459: 74689459
6 MOGS NM_006302.2(MOGS): c.1457G> C (p.Arg486Thr) single nucleotide variant Pathogenic rs121909291 GRCh38 Chromosome 2, 74462332: 74462332
7 MOGS NM_006302.2(MOGS): c.1954T> C (p.Phe652Leu) single nucleotide variant Pathogenic rs121909292 GRCh37 Chromosome 2, 74688962: 74688962
8 MOGS NM_006302.2(MOGS): c.1954T> C (p.Phe652Leu) single nucleotide variant Pathogenic rs121909292 GRCh38 Chromosome 2, 74461835: 74461835
9 MOGS NM_006302.2(MOGS): c.1838G> A (p.Arg613Gln) single nucleotide variant Conflicting interpretations of pathogenicity rs142032474 GRCh37 Chromosome 2, 74689078: 74689078
10 MOGS NM_006302.2(MOGS): c.1838G> A (p.Arg613Gln) single nucleotide variant Conflicting interpretations of pathogenicity rs142032474 GRCh38 Chromosome 2, 74461951: 74461951
11 MOGS NM_006302.2(MOGS): c.370C> T (p.Gln124Ter) single nucleotide variant Pathogenic rs587777323 GRCh37 Chromosome 2, 74691832: 74691832
12 MOGS NM_006302.2(MOGS): c.370C> T (p.Gln124Ter) single nucleotide variant Pathogenic rs587777323 GRCh38 Chromosome 2, 74464705: 74464705
13 MOGS NM_006302.2(MOGS): c.65C> A (p.Ala22Glu) single nucleotide variant no interpretation for the single variant rs753961807 GRCh37 Chromosome 2, 74692310: 74692310
14 MOGS NM_006302.2(MOGS): c.65C> A (p.Ala22Glu) single nucleotide variant no interpretation for the single variant rs753961807 GRCh38 Chromosome 2, 74465183: 74465183
15 MOGS NM_006302.2(MOGS): c.2055T> C (p.Tyr685=) single nucleotide variant Conflicting interpretations of pathogenicity rs202094225 GRCh37 Chromosome 2, 74688861: 74688861
16 MOGS NM_006302.2(MOGS): c.2055T> C (p.Tyr685=) single nucleotide variant Conflicting interpretations of pathogenicity rs202094225 GRCh38 Chromosome 2, 74461734: 74461734
17 MOGS NM_006302.2(MOGS): c.2353G> A (p.Gly785Ser) single nucleotide variant Benign/Likely benign rs35533773 GRCh38 Chromosome 2, 74461436: 74461436
18 MOGS NM_006302.2(MOGS): c.2353G> A (p.Gly785Ser) single nucleotide variant Benign/Likely benign rs35533773 GRCh37 Chromosome 2, 74688563: 74688563
19 MOGS NM_006302.2(MOGS): c.2032C> T (p.Arg678Trp) single nucleotide variant Benign/Likely benign rs13405869 GRCh38 Chromosome 2, 74461757: 74461757
20 MOGS NM_006302.2(MOGS): c.2032C> T (p.Arg678Trp) single nucleotide variant Benign/Likely benign rs13405869 GRCh37 Chromosome 2, 74688884: 74688884
21 MOGS NM_006302.2(MOGS): c.1587C> T (p.Asp529=) single nucleotide variant Conflicting interpretations of pathogenicity rs190772368 GRCh38 Chromosome 2, 74462202: 74462202
22 MOGS NM_006302.2(MOGS): c.1587C> T (p.Asp529=) single nucleotide variant Conflicting interpretations of pathogenicity rs190772368 GRCh37 Chromosome 2, 74689329: 74689329
23 MOGS NM_006302.2(MOGS): c.1509A> C (p.Leu503=) single nucleotide variant Conflicting interpretations of pathogenicity rs759481390 GRCh38 Chromosome 2, 74462280: 74462280
24 MOGS NM_006302.2(MOGS): c.1509A> C (p.Leu503=) single nucleotide variant Conflicting interpretations of pathogenicity rs759481390 GRCh37 Chromosome 2, 74689407: 74689407
25 MOGS NM_006302.2(MOGS): c.85C> G (p.Arg29Gly) single nucleotide variant Conflicting interpretations of pathogenicity rs369653963 GRCh38 Chromosome 2, 74465163: 74465163
26 MOGS NM_006302.2(MOGS): c.85C> G (p.Arg29Gly) single nucleotide variant Conflicting interpretations of pathogenicity rs369653963 GRCh37 Chromosome 2, 74692290: 74692290
27 MOGS NM_006302.2(MOGS): c.1245C> G (p.Ile415Met) single nucleotide variant Benign rs34838944 GRCh37 Chromosome 2, 74689671: 74689671
28 MOGS NM_006302.2(MOGS): c.1245C> G (p.Ile415Met) single nucleotide variant Benign rs34838944 GRCh38 Chromosome 2, 74462544: 74462544
29 MOGS NM_006302.2(MOGS): c.12C> G (p.Gly4=) single nucleotide variant Benign/Likely benign rs555329045 GRCh37 Chromosome 2, 74692363: 74692363
30 MOGS NM_006302.2(MOGS): c.12C> G (p.Gly4=) single nucleotide variant Benign/Likely benign rs555329045 GRCh38 Chromosome 2, 74465236: 74465236
31 MOGS NM_006302.2(MOGS): c.2112C> T (p.Pro704=) single nucleotide variant Benign rs561758565 GRCh38 Chromosome 2, 74461677: 74461677
32 MOGS NM_006302.2(MOGS): c.2112C> T (p.Pro704=) single nucleotide variant Benign rs561758565 GRCh37 Chromosome 2, 74688804: 74688804
33 MOGS NM_006302.2(MOGS): c.311A> C (p.Tyr104Ser) single nucleotide variant Uncertain significance rs1553380245 GRCh38 Chromosome 2, 74464937: 74464937
34 MOGS NM_006302.2(MOGS): c.311A> C (p.Tyr104Ser) single nucleotide variant Uncertain significance rs1553380245 GRCh37 Chromosome 2, 74692064: 74692064
35 MOGS NM_006302.2(MOGS): c.1825C> T (p.Arg609Cys) single nucleotide variant Uncertain significance rs369797433 GRCh37 Chromosome 2, 74689091: 74689091
36 MOGS NM_006302.2(MOGS): c.1825C> T (p.Arg609Cys) single nucleotide variant Uncertain significance rs369797433 GRCh38 Chromosome 2, 74461964: 74461964
37 MOGS NM_006302.2(MOGS): c.436T> G (p.Tyr146Asp) single nucleotide variant Uncertain significance rs576166441 GRCh37 Chromosome 2, 74691766: 74691766
38 MOGS NM_006302.2(MOGS): c.436T> G (p.Tyr146Asp) single nucleotide variant Uncertain significance rs576166441 GRCh38 Chromosome 2, 74464639: 74464639
39 MOGS NM_006302.2(MOGS): c.1049C> G (p.Pro350Arg) single nucleotide variant Uncertain significance rs754475101 GRCh38 Chromosome 2, 74462740: 74462740
40 MOGS NM_006302.2(MOGS): c.1049C> G (p.Pro350Arg) single nucleotide variant Uncertain significance rs754475101 GRCh37 Chromosome 2, 74689867: 74689867
41 MOGS NM_006302.2(MOGS): c.1581C> A (p.Asp527Glu) single nucleotide variant Likely benign rs200508287 GRCh37 Chromosome 2, 74689335: 74689335
42 MOGS NM_006302.2(MOGS): c.1581C> A (p.Asp527Glu) single nucleotide variant Likely benign rs200508287 GRCh38 Chromosome 2, 74462208: 74462208
43 MOGS NM_006302.2(MOGS): c.1294G> C (p.Val432Leu) single nucleotide variant Likely benign rs552488837 GRCh38 Chromosome 2, 74462495: 74462495
44 MOGS NM_006302.2(MOGS): c.1294G> C (p.Val432Leu) single nucleotide variant Likely benign rs552488837 GRCh37 Chromosome 2, 74689622: 74689622
45 MOGS NM_006302.2(MOGS): c.947A> T (p.Gln316Leu) single nucleotide variant Uncertain significance rs1553379896 GRCh37 Chromosome 2, 74689969: 74689969
46 MOGS NM_006302.2(MOGS): c.947A> T (p.Gln316Leu) single nucleotide variant Uncertain significance rs1553379896 GRCh38 Chromosome 2, 74462842: 74462842
47 MOGS NM_006302.2(MOGS): c.858G> C (p.Gln286His) single nucleotide variant Uncertain significance rs202095654 GRCh37 Chromosome 2, 74690058: 74690058
48 MOGS NM_006302.2(MOGS): c.858G> C (p.Gln286His) single nucleotide variant Uncertain significance rs202095654 GRCh38 Chromosome 2, 74462931: 74462931
49 MOGS NM_006302.2(MOGS): c.664G> A (p.Gly222Arg) single nucleotide variant Likely benign rs3213671 GRCh37 Chromosome 2, 74690429: 74690429
50 MOGS NM_006302.2(MOGS): c.664G> A (p.Gly222Arg) single nucleotide variant Likely benign rs3213671 GRCh38 Chromosome 2, 74463302: 74463302

Expression for Congenital Disorder of Glycosylation, Type Iib

Search GEO for disease gene expression data for Congenital Disorder of Glycosylation, Type Iib.

Pathways for Congenital Disorder of Glycosylation, Type Iib

Pathways related to Congenital Disorder of Glycosylation, Type Iib according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.51 CALR CANX MAN1B1 MOGS
2
Show member pathways
11.54 MGAM SI
3 11.47 CALR CANX MAN1B1 MOGS
4
Show member pathways
11.22 MAN1B1 MOGS
5
Show member pathways
11.17 CANX MAN1B1
6 11.01 MGAM SI
7
Show member pathways
10.85 CALR CANX MAN1B1 MOGS
8 10.65 CALR CANX
9 10.11 MGAM SI

GO Terms for Congenital Disorder of Glycosylation, Type Iib

Cellular components related to Congenital Disorder of Glycosylation, Type Iib according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 integral component of membrane GO:0016021 9.88 CANX CHL1 MAN1B1 MGAM MOGS SI
2 membrane GO:0016020 9.87 CALR CANX CHL1 MAN1B1 MGAM MOGS
3 endoplasmic reticulum GO:0005783 9.67 CALR CANX MAN1B1 MOGS
4 extracellular exosome GO:0070062 9.43 CALR CANX CHL1 MGAM MOGS SI
5 integral component of lumenal side of endoplasmic reticulum membrane GO:0071556 9.26 CALR CANX
6 smooth endoplasmic reticulum GO:0005790 9.16 CALR CANX
7 endoplasmic reticulum quality control compartment GO:0044322 8.8 CALR CANX MAN1B1

Biological processes related to Congenital Disorder of Glycosylation, Type Iib according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein folding GO:0006457 9.5 CALR CANX MOGS
2 antigen processing and presentation of peptide antigen via MHC class I GO:0002474 9.37 CALR CANX
3 protein folding in endoplasmic reticulum GO:0034975 9.26 CALR CANX
4 oligosaccharide metabolic process GO:0009311 9.16 MAN1B1 MOGS
5 polysaccharide digestion GO:0044245 8.96 MGAM SI
6 metabolic process GO:0008152 8.92 MAN1B1 MGAM MOGS SI

Molecular functions related to Congenital Disorder of Glycosylation, Type Iib according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 hydrolase activity GO:0016787 9.67 MAN1B1 MGAM MOGS SI
2 calcium ion binding GO:0005509 9.58 CALR CANX MAN1B1
3 unfolded protein binding GO:0051082 9.32 CALR CANX
4 hydrolase activity, hydrolyzing O-glycosyl compounds GO:0004553 9.26 MGAM SI
5 carbohydrate binding GO:0030246 9.26 CALR CANX MGAM SI
6 alpha-1,4-glucosidase activity GO:0004558 9.16 MGAM SI
7 hydrolase activity, acting on glycosyl bonds GO:0016798 8.92 MAN1B1 MGAM MOGS SI

Sources for Congenital Disorder of Glycosylation, Type Iib

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....